Comments

Ocugen Stock Price, Quotes and Forecasts

Q: What sector and industry does Ocugen (OCGN) operate in?

Ocugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

OCGNNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$1.09

At close: Jun 18 EDT

$1.10

0.010.92%

Pre-Market: 5:13 AM EDT

Ocugen (OCGN) Forecast

News Earnings Ocugen (OCGN) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Ocugen Stock Price, Quotes and Forecasts | NASDAQ:OCGN | Benzinga

Explore Ocugen stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for OCGN.

Open	-
Close	-
Volume / Avg.	20.90K / 4.51M
Day Range	- - -
52 Wk Range	0.52 - 1.98
Market Cap	$321.23M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	23.83%
Days to Cover	10.73

Recent News

Ocugen (OCGN) Stock Soars On FDA Clearance For Pivotal Stargardt Disease Trial

Ocugen's gene therapy for Stargardt disease is now advancing to a pivotal trial. The company's treatment could help patients who currently have no other options.

Henry Khederian

Marriott International To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday

Avi Kapoor

Why Ocugen (OCGN) Stock Is Falling

Ocugen shares are trading lower by 11% Thursday morning. The company announced the pricing of its public offering.

Henry Khederian

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Feb

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	20.90K / 4.51M
Day Range	- - -
52 Wk Range	0.52 - 1.98
Market Cap	$321.23M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	55
Short Interest	23.83%
Days to Cover	10.73

About Ocugen Inc

Sector

Health Care

Industry

Biotechnology

Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell thera...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Ocugen (OCGN) stock?

You can purchase shares of Ocugen (NASDAQ:OCGN) through any online brokerage.

View our list of the best stock brokerages

Who are Ocugen (OCGN) competitors?

Other companies in Ocugen’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Humacyte (NASDAQ:HUMA), Prothena Corp (NASDAQ:PRTA), Monte Rosa Therapeutics (NASDAQ:GLUE) and Abeona Therapeutics (NASDAQ:ABEO).

What is the forecast, or price target, for Ocugen (OCGN) stock?

Ocugen has a consensus price target of $4.60.

What is the current price for Ocugen (OCGN)?

The stock price for Ocugen (NASDAQ: OCGN) is $1.1 last updated June 18, 2025 at 5:13 AM EDT.

Does Ocugen (OCGN) pay a dividend?

There are no upcoming dividends for Ocugen.

When is Ocugen (NASDAQ:OCGN) reporting earnings?

Ocugen’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Ocugen (OCGN) going to split?

There is no upcoming split for Ocugen.

What sector and industry does Ocugen (OCGN) operate in?

Ocugen is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.